J

Jazz Pharmaceuticals

Biopharmaceuticals focused on neuroscience and oncology

Global Medical Director - Epilepsy Pipeline

Biology & BiotechConfirmed live in the last 24 hours
Full-time$268k - $402kRemote

About the Job

Requirements

  • Significant (10+ years) of Medical Affairs, Clinical Development, or related pharmaceutical or biotechnology industry experience, preferably in epilepsy and neuroscience disorders.
  • A strong clinical or scientific background in the epilepsy therapeutic area.
  • Demonstrated experience developing and executing evidence-generation strategies, publication plans, and external scientific engagement activities.
  • A strong understanding of clinical research, evidence generation, and neuroscience drug development.
  • The ability to influence without authority and operate effectively within complex matrix organizations.
  • Strong strategic thinking and operational execution skills.
  • Excellent written, verbal, presentation, and stakeholder management skills.
  • The ability to build productive partnerships across regions and functions and effectively represent diverse stakeholder perspectives.
  • Demonstrated ability to manage multiple priorities and deliver high-quality outcomes in a fast-paced environment.
  • Evidence of success in matrix organizations and a track record of high-performing behaviors, including independent critical thinking, initiative, and execution under time pressure with competing priorities.
  • Self-awareness and emotional intelligence, demonstrated through experience navigating complex matrix environments successfully.
  • An advanced scientific or healthcare degree, specifically PharmD, PhD, MD, or equivalent.

Responsibilities

  • Lead the Medical Functional Matrix Team for ABS-1230 and support the epilepsy pipeline, including other potential new indications across the epilepsy portfolio.
  • Partner with US and EUR/INT Medical Affairs teams to understand regional customer, patient, healthcare provider, and healthcare system needs and priorities.
  • Represent and advocate for medical perspectives within global cross-functional teams and governance forums, including EDT, LDT, GPT, PGC, and DPRC.
  • Contribute Medical Affairs expertise to early development activities, including Target Product Profile development, clinical trial design, and lifecycle planning based on regional insights and aligned future therapeutic landscape scenarios.
  • Ensure regional needs and insights are considered in clinical development discussions, evidence-generation activities, and lifecycle planning.
  • Ensure awareness and Medical Affairs functional alignment on clinical development programs.
  • Maintain and apply a deep understanding of the competitive landscape to inform evidence-generation strategy and internal development decisions.
  • Lead the development, maintenance, and execution of the Integrated Evidence Generation Plan for ABS-1230 and other Jazz pipeline assets.
  • Partner across Medical Affairs, Clinical Development, Regulatory Affairs, Market Access, Health Economics and Outcomes Research, Real-World Evidence, Commercial, and other cross-functional teams to support evidence generation and scientific exchange.
  • Lead and support evidence-generation activities, including investigator-sponsored studies, real-world evidence initiatives, health outcomes research, and Phase IV interventional studies where appropriate.
  • Lead development of the epilepsy pipeline scientific narrative by identifying and advancing key analytic needs and informing interpretation of pivotal trial data.
  • Lead development of publication strategy with the Medical Communications team, aligned with regional evidence needs and scientific priorities.
  • Support scientific communications, congress planning, advisory boards, and external engagement activities as required.
  • Act as an epilepsy subject matter expert for internal cross-functional stakeholders.

Desired Qualifications

  • Experience in lifecycle management of epilepsy or neuroscience indications is strongly desired.

About the Company

Jazz Pharmaceuticals

Biopharmaceuticals focused on neuroscience and oncology

Jazz Pharmaceuticals is a global biopharmaceutical company focused on neuroscience and oncology, developing and selling therapies for diseases with limited options. Its portfolio includes Xyrem/Xywav for narcolepsy, Epidiolex for seizures, Zepzelca for small cell lung cancer, and Vyxeos for AML. The company grows through a mix of in-house R&D and strategic acquisitions (like GW Pharmaceuticals, Celator, Chimerix) to expand its pipeline. Its goal is to broaden approved therapies and reach patients with limited options by building a diversified, specialty-focused portfolio.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dublin, Ireland
Founded
2003

Recently Posted Jobs

Explore more opportunities at Jazz Pharmaceuticals

See more jobs